Floatz logo

Cholalic Acid

Zellweger Spectrum Disorders

Mirum Pharmaceuticals, Inc.Small moleculePhase 3Dormant
B
56/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
41/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Zellweger Spectrum Disorders cohort.

Asset / SponsorPhaseRating
Hydroxychloroquine
The Hospital for Sick Children
Phase 2B
Cald Hr-D
Masonic Cancer Center, University of Minnesota
Phase 2CCC

Same molecule, other indications

Cholalic Acid is also rated in:

adrenoleukodystrophyDormant
B
Indicative · Phase 3
56 / 100
View asset →
peroxisome biogenesis disorderDormant
B
Indicative · Phase 3
56 / 100
View asset →
peroxisomal diseaseDormant
B
Indicative · Phase 3
56 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →